MORGAN STANLEY PLC/CALL/EDWARDS LIFESCIENCES/140/0.1/20.09.24 | Market Closed - Börse Stuttgart 12:02:41 18/05/2024 am IST | ||
| 0.034 EUR | 0.00% |
|
| 1 month | -22.73% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 0.034 | 0.00% |
| 16/24/16 | 0.034 | 0.00% |
| 15/24/15 | 0.034 | +6.25% |
| 14/24/14 | 0.032 | -3.03% |
| 13/24/13 | 0.033 | 0.00% |
Delayed Quote Börse Stuttgart
Last update May 18, 2024 at 12:02 am IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | Morgan Stanley |
| WKN | MG007N |
| ISIN | DE000MG007N7 |
| Date issued | 11/03/2024 |
| Strike | 140 $ |
| Maturity | 20/09/2024 (126 Days) |
| Parity | 10 : 1 |
| Emission price | 0.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.07 € |
|---|---|
| Lowest since issue | 0.024 € |
| Spread | 0.006 € |
| Spread % | 15.00% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.14
USD
Average target price
95.9
USD
Spread / Average Target
+7.59%
- Stock Market
- Warrants
- Warrant
